日本語フィールド
著者：*H Takahashi, H Nomura, H Iriki, A Kubo, K Isami, Y Mikami, M Mukai, T Sasaki, J Yamagami, J Kudoh, H Ito, A Kamata, Y Kurebayashi, H Yoshida, A Yoshimura, H W Sun, M Suematsu, J J O'Shea, Y Kanno, M Amagai題名：Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin発表情報：Sci Immunol 巻: 6 号: 64 ページ: eabb6444キーワード：概要：Interleukin-27 (IL-27) is a cytokine with known immunoregulatory effects based on prior studies of IL-27–deficient mice, but the mechanisms contributing to IL-27’s suppressive effects are still poorly understood. Takahashi et al. identified the gene encoding cholesterol 25-hydroxylase (Ch25h), the enzyme that converts cholesterol to 25-hydroxycholesterol (25OHC), as strongly and selectively induced in T cells stimulated with IL-27 versus other combinations of cytokines. Extracellular 25OHC selectively impaired in vitro growth of activated T cells through impairment of cholesterol biosynthesis while sparing quiescent T cells. In autoreactive T cells capable of inducing dermatitis after adoptive transfer, genetic absence of Ch25h or the IL-27 receptor resulted in more severe skin disease. These findings identify IL-27–induced 25OHC as immunomodulatory cholesterol metabolite with therapeutic potential in autoimmune and inflammatory diseases.抄録：Interleukin-27 (IL-27) is an immunoregulatory cytokine whose essential function is to limit immune responses. We found that the gene encoding cholesterol 25-hydroxylase (Ch25h) was induced in CD4+ T cells by IL-27, enhanced by transforming growth factor–β (TGF-β), and antagonized by T-bet. Ch25h catalyzes cholesterol to generate 25-hydroxycholesterol (25OHC), which was subsequently released to the cellular milieu, functioning as a modulator of T cell response. Extracellular 25OHC suppressed cholesterol biosynthesis in T cells, inhibited cell growth, and induced nutrient deprivation cell death without releasing high-mobility group box 1 (HMGB1). This growth inhibitory effect was specific to actively proliferating cells with high cholesterol demand and was reversed when extracellular cholesterol was replenished. Ch25h-expressing CD4+ T cells that received IL-27 and TGF-β signals became refractory to 25OHC-mediated growth inhibition in vitro. Nonetheless, IL-27–treated T cells negatively affected viability of bystander cells in a paracrine manner, but only if the bystander cells were in the early phases of activation. In mouse models of skin inflammation due to autoreactive T cells or chemically induced hypersensitivity, genetic deletion of Ch25h or Il27ra led to worse outcomes. Thus, Ch25h is an immunoregulatory metabolic switch induced by IL-27 and dampens excess bystander T effector expansion in tissues through its metabolite derivative, 25OHC. This study reveals regulation of cholesterol metabolism as a modality for controlling tissue inflammation and thus represents a mechanism underlying T cell immunoregulatory functions.英語フィールド
Author：*H Takahashi, H Nomura, H Iriki, A Kubo, K Isami, Y Mikami, M Mukai, T Sasaki, J Yamagami, J Kudoh, H Ito, A Kamata, Y Kurebayashi, H Yoshida, A Yoshimura, H W Sun, M Suematsu, J J O'Shea, Y Kanno, M AmagaiTitle：Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skinAnnouncement information:Sci Immunol Vol: 6 Issue: 64 Page: eabb6444An abstract：Interleukin-27 (IL-27) is a cytokine with known immunoregulatory effects based on prior studies of IL-27–deficient mice, but the mechanisms contributing to IL-27’s suppressive effects are still poorly understood. Takahashi et al. identified the gene encoding cholesterol 25-hydroxylase (Ch25h), the enzyme that converts cholesterol to 25-hydroxycholesterol (25OHC), as strongly and selectively induced in T cells stimulated with IL-27 versus other combinations of cytokines. Extracellular 25OHC selectively impaired in vitro growth of activated T cells through impairment of cholesterol biosynthesis while sparing quiescent T cells. In autoreactive T cells capable of inducing dermatitis after adoptive transfer, genetic absence of Ch25h or the IL-27 receptor resulted in more severe skin disease. These findings identify IL-27–induced 25OHC as immunomodulatory cholesterol metabolite with therapeutic potential in autoimmune and inflammatory diseases.An abstract：Interleukin-27 (IL-27) is an immunoregulatory cytokine whose essential function is to limit immune responses. We found that the gene encoding cholesterol 25-hydroxylase (Ch25h) was induced in CD4+ T cells by IL-27, enhanced by transforming growth factor–β (TGF-β), and antagonized by T-bet. Ch25h catalyzes cholesterol to generate 25-hydroxycholesterol (25OHC), which was subsequently released to the cellular milieu, functioning as a modulator of T cell response. Extracellular 25OHC suppressed cholesterol biosynthesis in T cells, inhibited cell growth, and induced nutrient deprivation cell death without releasing high-mobility group box 1 (HMGB1). This growth inhibitory effect was specific to actively proliferating cells with high cholesterol demand and was reversed when extracellular cholesterol was replenished. Ch25h-expressing CD4+ T cells that received IL-27 and TGF-β signals became refractory to 25OHC-mediated growth inhibition in vitro. Nonetheless, IL-27–treated T cells negatively affected viability of bystander cells in a paracrine manner, but only if the bystander cells were in the early phases of activation. In mouse models of skin inflammation due to autoreactive T cells or chemically induced hypersensitivity, genetic deletion of Ch25h or Il27ra led to worse outcomes. Thus, Ch25h is an immunoregulatory metabolic switch induced by IL-27 and dampens excess bystander T effector expansion in tissues through its metabolite derivative, 25OHC. This study reveals regulation of cholesterol metabolism as a modality for controlling tissue inflammation and thus represents a mechanism underlying T cell immunoregulatory functions.